Related Experiment Videos
[Benzodiazepine withdrawal with carbamazepine]
S H Kaendler1, S Volk, B Pflug
1Neurologische Klinik, Klinikum Aschaffenburg, Frankfurt am Main.
Der Nervenarzt
|May 1, 1996
Summary
Carbamazepine (CBZ) facilitates abrupt benzodiazepine withdrawal in patients with panic disorder or neurosis, reducing hospitalization. Continuous after-care is crucial to prevent relapse due to recurring anxiety.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Context:
- Benzodiazepine dependence is a significant clinical challenge, often linked to anxiety disorders.
- Abrupt withdrawal can lead to severe symptoms, necessitating effective management strategies.
Purpose:
- To evaluate the efficacy and tolerability of abrupt benzodiazepine withdrawal using carbamazepine (CBZ).
- To compare abrupt withdrawal with CBZ to gradual tapering methods.
Summary:
- Seventeen patients with long-term benzodiazepine dependence underwent abrupt withdrawal with carbamazepine (400 mg twice daily).
- Most patients experienced manageable withdrawal symptoms like anxiety and sleep disturbances; perception disturbances were noted in 14.
- No epileptic seizures occurred, and CBZ was well-tolerated, suggesting abrupt withdrawal with CBZ may be better tolerated than gradual tapering, potentially shortening hospitalization.
Impact:
- This approach may offer a more tolerable and efficient method for benzodiazepine withdrawal, reducing hospital stays.
- Highlights the need for ongoing after-care to address potential anxiety recurrence and prevent re-dependence.